Bausch Health Companies (NYSE:BHC) Announces Quarterly Earnings Results

Bausch Health Companies (NYSE:BHC) posted its earnings results on Wednesday. The company reported $1.21 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.65 by ($0.44), Zacks reports. Bausch Health Companies had a negative net margin of 1.88% and a negative return on equity of 755.86%. Bausch Health Companies updated its FY 2025 guidance to EPS.

Bausch Health Companies Trading Up 2.9 %

Shares of NYSE BHC traded up $0.18 during trading hours on Wednesday, reaching $6.54. The stock had a trading volume of 2,885,751 shares, compared to its average volume of 3,337,500. The firm has a market cap of $2.37 billion, a price-to-earnings ratio of -13.63, a PEG ratio of 0.32 and a beta of 0.68. Bausch Health Companies has a fifty-two week low of $3.96 and a fifty-two week high of $11.46. The firm has a 50-day moving average of $7.39 and a 200-day moving average of $7.47.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on BHC shares. Royal Bank of Canada decreased their price target on shares of Bausch Health Companies from $11.00 to $10.00 and set a “sector perform” rating on the stock in a research note on Thursday, January 30th. StockNews.com upgraded shares of Bausch Health Companies from a “hold” rating to a “buy” rating in a report on Friday, October 25th. Finally, Jefferies Financial Group restated a “hold” rating and set a $8.00 price target (down previously from $12.00) on shares of Bausch Health Companies in a report on Thursday, February 6th. One analyst has rated the stock with a sell rating, six have issued a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat, Bausch Health Companies presently has an average rating of “Hold” and a consensus price target of $7.42.

About Bausch Health Companies

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.